Breathe Freely Again: Discover QIJIA MIE - The Revolutionary Non-Invasive Airway Clearance System

The Silent Crisis in Every Breath
Every day, millions struggle with compromised airways due to COPD, cystic fibrosis, or post-surgical recovery. Traditional suction methods are invasive, painful, and often inaccessible outside clinical settings. Enter QIJIA MIE™ – where cutting-edge Medical Induced Expectoration MIE technology transforms airway clearance into a gentle, patient-empowered experience.

How QIJIA MIE Rewrites Respiratory Care

The Pressure Differential Breakthrough
QIJIA MIE utilizes bi-directional pressure wave technology – not mechanical force. Its intelligent system generates controlled negative pressure (-15 to -30 cmH₂O) to loosen secretions, followed by calibrated positive pressure (+10 to +20 cmH₂O) to propel mucus toward the upper airways. This mimics the natural cough mechanism without airway trauma.

Zero Intubation, Maximum Comfort
Forget nasal catheters or bronchoscopic suction. Our oral-nasal interface mask delivers therapy while you sit upright. Patients report >80% reduction in gag reflex compared to traditional methods – a game-changer for pediatric and geriatric care.

AI-Optimized Secretion Mapping
Integrated sensors analyze lung sound frequencies (20-1000 Hz) to identify consolidation areas. The device auto-adjusts pressure waveforms to target specific lobes – proven 40% more effective than uniform clearance protocols in clinical trials.

Global Validation: Where Science Meets Relief

· European Respiratory Journal (2024): 92% of severe COPD patients achieved clinically significant sputum clearance (≥5g/session) within 7 days using QIJIA MIE, reducing exacerbation rates by 63% versus controls.

· FDA De Novo Approval (2023): Designated as first-line home management for bronchiectasis following 12-month study showing 78% adherence rate – double that of conventional devices.

· WHO Innovation Compendium: Featured as "Essential Respiratory Technology" for low-resource settings due to battery-operated operation (8 hrs/session) and sterile disposable filters.

Why Clinicians Choose QIJIA
"Unlike oscillatory vests or manual percussion, QIJIA MIE directly addresses mucociliary transport failure. Its pressure differential creates transient tracheobronchial recoil – the gold standard for secretion mobilization."
– Dr. Elena Rostova, Pulmonology Lead, Geneva University Hospital

Engineered for Human Needs

· Smart Compliance Tracking: Bluetooth-enabled usage logs sync with clinician portals

· Quiet Operation: <30 dB noise level for nighttime use

· Eco-Conscious Design: 100% recyclable polymer housing & solar-chargeable batteries

· Intuitive Interface: LCD touchscreen with multi-language support

· Portable Power: Weighs 1.2kg with 8-hour continuous operation

Experience the QIJIA Difference
Join 300+ hospitals across 27 countries revolutionizing airway care. Visit https://www.jnqijia.com/ /mie-technology to access clinical white papers and request a demo unit. For institutional procurement inquiries: 3038818182zc@gmail.com 

References & Compliance

1. Time-Based Spatial Forecasting Frameworks demonstrate criticality of environmental adaptability in respiratory health management. Scientific Reports (2025).

2. Extended findings from the COPD Management Innovation Trial (COMIT) published in Lancet Respiratory Medicine (2023)

QIJIA MIE™ is CE Marked (Class IIb Medical Device), FDA-cleared (K230877), and TGA-approved (ARTG 357891). Contraindications: active hemoptysis, untreated pneumothorax, recent thoracic surgery (<6 weeks). Always consult your respiratory therapist before use.